Form 4 for GILD Gilead Sciences
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-10 · accession 0001127602-25-009290 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | +3,343 | 37.7K | +10% | — |
| D | 2025-03-12 | 2025-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | F - Tax | $117.21 | -1,130 | 36.6K | -3% | -$132.4K |
| D | 2025-03-12 | 2025-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | M - OptEx | — | -3,343 | 24.4K | -12% | — |
| DM | 2025-03-12 | 2025-03-10 | GILD | Telman Deborah H | EVP, GC, Corp. Affairs | A - Grant | $0.00 | +41.6K | 33.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | M | A | 3,343 | — | 37,692 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 2 | Common | Common Stock | 2025-03-10 | F | D | 1,130 | $117.21 | 36,562 | D | — | — | (F2) Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |
| 3 | Derivative | Restricted Stock Unit | 2025-03-10 | M | D | 3,343 | — | 24,356 | D | — · — to — | 3,343 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 4 | Derivative | Restricted Stock Unit | 2025-03-10 | A | A | 7,680 | — | 32,216 | D | — · — to — | 7,680 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2025-03-10 | A | A | 33,940 | $0.00 | 33,940 | D | $117.21 · — to 2035-03-10 | 33,940 Common Stock | (F4) The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. |